Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (6)

1

Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain

enthalten in: F1000Research | 2022

von Benitez Fuentes, J. | de Luna Aguilar, A. | Jimenez Ortega, A. | +9

2

Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV : prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target

enthalten in: F1000Research | 2020

von Veljkovic, V. | Vergara-Alert, J. | Segalés, J. | +1

3

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure : virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates

enthalten in: F1000Research | 2020

von Chen, Y. | Yiu, C. | Wong, K.

CommentIn: J Hepatol. 2020 Nov;73(5):1262-1263. - PMID 32673740

4

Lithium and coronaviral infections. A scoping review

enthalten in: F1000Research | 2020

von Nowak, J. | Walkowiak, J.

5

A snapshot of the ongoing clinical research on COVID-19

enthalten in: F1000Research | 2020

von Piovani, D. | Pansieri, C. | Peyrin-Biroulet, L. | +2

6

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China

enthalten in: F1000Research | 2020

von Kruse, R.

1
[1]